ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.320
-1.760 (-57.14%)
At close: Jun 4, 2026, 4:00 PM EDT
1.360
+0.040 (3.01%)
Pre-market: Jun 5, 2026, 7:03 AM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $167.89 million as of June 5, 2026. Its market cap has decreased by -27.66% in one year.
Market Cap
167.89M
Enterprise Value
373.14M
1-Year Change
-27.66%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $167.89M, a decrease of -91.78%. That is a compound annual growth rate of -33.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 391.75M | -10.41% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 417.39M |
| Forte Biosciences | 415.41M |
| Upstream Bio | 415.22M |
| Neurogene | 414.33M |
| vTv Therapeutics | 408.77M |
| Monopar Therapeutics | 405.68M |
| Compass Therapeutics | 378.18M |
| X4 Pharmaceuticals | 374.45M |